Free Trial
NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

$21.44
+0.94 (+4.59%)
(As of 10:51 AM ET)
Today's Range
$20.14
$21.98
50-Day Range
$4.34
$20.63
52-Week Range
$4.16
$49.47
Volume
30,187 shs
Average Volume
34,517 shs
Market Capitalization
$106.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00

Nutex Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
119.5% Upside
$45.00 Price Target
Short Interest
Healthy
2.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of Nutex Health in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$69,845 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.43 out of 5 stars

Medical Sector

420th out of 924 stocks

Business Services, Not Elsewhere Classified Industry

62nd out of 88 stocks

NUTX stock logo

About Nutex Health Stock (NASDAQ:NUTX)

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

NUTX Stock Price History

NUTX Stock News Headlines

Buy these “two-bagger” stocks
We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.
Nutex Health (NUTX) Q2 2024 Earnings Call Transcript
Kovo HealthTech Corporation (KOVO.V)
Buy these “two-bagger” stocks
We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.
See More Headlines
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2024
Today
8/22/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
Business Services
Current Symbol
NASDAQ:NUTX
Employees
1,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$45.00
High Stock Price Target
$45.00
Low Stock Price Target
$45.00
Potential Upside/Downside
+119.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-45,790,000.00
Pretax Margin
-15.77%

Debt

Sales & Book Value

Annual Sales
$275.93 million
Book Value
$17.68 per share

Miscellaneous

Free Float
3,057,000
Market Cap
$101.93 million
Optionable
Not Optionable
Beta
-0.07
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Thomas T. Vo M.B.A. (Age 51)
    M.D., Chairman of the Board & CEO
    Comp: $938.23k
  • Dr. Warren Hosseinion M.D. (Age 52)
    President & Director
    Comp: $937.66k
  • Mr. Jon C. Bates CPA (Age 53)
    M.B.A., Chief Financial Officer
    Comp: $299.46k
  • Ms. Pamela W. Montgomery B.S.N. (Age 58)
    J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Secretary
    Comp: $275.36k
  • Ms. Elisa Michael Luqman Esq. (Age 60)
    J.D., M.B.A., Chief Legal Officer (SEC) & Board Secretary
    Comp: $251.33k
  • Mr. Joshua DeTillio FACHE
    M.B.A., Chief Operating Officer
  • Ms. LaChoenda Rosales
    Director of Accounting
  • LaTanya Brackens
    Director of Compliance
  • Ms. Vivian Sanders M.B.A.
    Director of Marketing
  • Sarah Wallace
    Director of Human Resources

NUTX Stock Analysis - Frequently Asked Questions

How have NUTX shares performed this year?

Nutex Health's stock was trading at $27.00 on January 1st, 2024. Since then, NUTX shares have decreased by 24.1% and is now trading at $20.50.
View the best growth stocks for 2024 here
.

How were Nutex Health's earnings last quarter?

Nutex Health Inc. (NASDAQ:NUTX) announced its quarterly earnings data on Thursday, August, 8th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.22. The business earned $76.08 million during the quarter. Nutex Health had a negative trailing twelve-month return on equity of 44.06% and a negative net margin of 15.85%.

When did Nutex Health's stock split?

Nutex Health's stock reverse split before market open on Wednesday, July 3rd 2024. The 1-10 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Nutex Health's major shareholders?

Top institutional investors of Nutex Health include Truist Financial Corp (5.86%), GDS Wealth Management (1.49%) and Renaissance Technologies LLC (1.14%). Insiders that own company stock include Thomas T Vo, Joshua Detillio, John J Waters, Pamela W Montgomery and Michael Lee Reed.
View institutional ownership trends
.

How do I buy shares of Nutex Health?

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NUTX) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners